Template:WUR

From 2012.igem.org

(Difference between revisions)
 
(13 intermediate revisions not shown)
Line 40: Line 40:
     <ul>
     <ul>
       <li>[[Team:Wageningen_UR/Project|1. Introduction]]</li>
       <li>[[Team:Wageningen_UR/Project|1. Introduction]]</li>
-
       <li>[[Team:Wageningen_UR/Coil_system|2. PnAS]]</li>
+
       <li>[[Team:Wageningen_UR/Coil_system|2. PnA System]]</li>
       <li class="hassubitems">
       <li class="hassubitems">
         <span>[[Team:Wageningen_UR/VLPs|3. Virus-Like Particles]]</span>
         <span>[[Team:Wageningen_UR/VLPs|3. Virus-Like Particles]]</span>
Line 62: Line 62:
       <li>[[Team:Wageningen_UR/miniSymposium#Online_video_symposium|1. Mini Symposium]]</li>
       <li>[[Team:Wageningen_UR/miniSymposium#Online_video_symposium|1. Mini Symposium]]</li>
       <li>[[Team:Wageningen_UR/Visiting_Secondary_School#Visiting_Secondary_Schools|2. Visiting Secondary Schools]]</li>
       <li>[[Team:Wageningen_UR/Visiting_Secondary_School#Visiting_Secondary_Schools|2. Visiting Secondary Schools]]</li>
-
       <li>[[Team:Wageningen_UR/DiscoveryFestival#Discovery_festival|3. Discovery Festival]]</li>
+
       <li class="hassubitems">
 +
        [[Team:Wageningen_UR/DiscoveryFestival#Discovery_festival|3. Discovery Festival]]
 +
        <ul><li>[[Team:Team:Wageningen_UR/DiscoveryFestival_Communication|Communication Science]]</li></ul>
 +
      </li>
       <li>[[Team:Wageningen_UR/Stakeholders#Stakeholders|4. Stakeholders]]</li>
       <li>[[Team:Wageningen_UR/Stakeholders#Stakeholders|4. Stakeholders]]</li>
       <li>[[Team:Wageningen_UR/CASconference#Synthetic_Biology_CAS-conference_Munich|5. Munich CAS Conference]]</li>
       <li>[[Team:Wageningen_UR/CASconference#Synthetic_Biology_CAS-conference_Munich|5. Munich CAS Conference]]</li>
Line 75: Line 78:
       <li>[[Team:Wageningen_UR/Regulations|3. Regulations]]</li>
       <li>[[Team:Wageningen_UR/Regulations|3. Regulations]]</li>
       <li>[[Team:Wageningen_UR/Possible_Improvements|4. Safety suggestions]]</li>
       <li>[[Team:Wageningen_UR/Possible_Improvements|4. Safety suggestions]]</li>
 +
      <li>[[Team:Wageningen_UR/Application_safety|5. Safety of applications]]</li>
     </ul>
     </ul>
 +
  </li>
 +
  <li>
 +
    <span>[[Team:Wageningen_UR/Modeling|Modeling]]</span>
 +
    <ul>
 +
      <li><span>[[Team:Wageningen_UR/HumanBody|Human Body Model]]</span></li>
 +
      <li><span>[[Team:Wageningen_UR/InSilico|Tertiary folding prediction]]</span></li>
 +
      <li><span>[[Team:Wageningen_UR/FormationModel|VLP assembly model]]</span></li>
 +
          </ul>
   </li>
   </li>
   <li><span>[[Team:Wageningen_UR/Attributions|Attributions]]</span></li>
   <li><span>[[Team:Wageningen_UR/Attributions|Attributions]]</span></li>
   <li><span>[[Team:Wageningen_UR/Parts|Parts]]</span></li>
   <li><span>[[Team:Wageningen_UR/Parts|Parts]]</span></li>
-
  <li><span>[[Team:Wageningen_UR/Modeling|Modeling]]</span></li>
 
   <li>
   <li>
     <span>[[Team:Wageningen_UR/Notebook|Notebook]]</span>
     <span>[[Team:Wageningen_UR/Notebook|Notebook]]</span>
Line 140: Line 151:
<div class="fullfooter">
<div class="fullfooter">
-
<html><img src="https://static.igem.org/mediawiki/2012/1/11/Wur_sponsors.png" alt="We thank our sponsors: DSM, Middelhoven Fund, AFSG, NBV, VLAG and Gilson!" /></html>
+
<html>
 +
<h4>Our Sponsors:</h4>
 +
<img src="https://static.igem.org/mediawiki/2012/1/11/Wur_sponsors.png" alt="We thank our sponsors: AFSG, Agilent Technologies, Baseclear, DSM, ERASynBio, Gilson, Middelhoven Fund, NBV, SBN, SurfRender, VLAG, Wageningen UR" /></html>
</div>
</div>
</div>
</div>

Latest revision as of 18:03, 26 October 2012